Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | K |
| Molecular Weight | 39.0983 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[K]
InChI
InChIKey=NTTOTNSKUYCDAV-UHFFFAOYSA-N
InChI=1S/K.H
| Molecular Formula | K |
| Molecular Weight | 39.0983 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| TRPM4, a Ca2+-activated nonselective cation channel in mouse sino-atrial node cells. | 2007-02-01 |
|
| TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. | 2007-02 |
|
| Hypokalemic rhabdomyolysis in a child due to amphotericin B therapy. | 2007-02 |
|
| Testosterone and progesterone rapidly attenuate plasma membrane Gbetagamma-mediated signaling in Xenopus laevis oocytes by signaling through classical steroid receptors. | 2007-01 |
|
| The effect of high extracellular potassium on IKr inhibition by anti-arrhythmic agents. | 2007 |
|
| Functional expression of the TRPM4 cationic current in ventricular cardiomyocytes from spontaneously hypertensive rats. | 2006-10 |
|
| Adaptive downregulation of a quinidine-sensitive cation conductance in renal principal cells of TWIK-1 knockout mice. | 2006-10 |
|
| Zinc-induced aggregation of Abeta (10-21) potentiates its action on voltage-gated potassium channel. | 2006-06-23 |
|
| Activation and enzymatic characterization of recombinant human kallikrein 8. | 2006-06 |
|
| Clinical evaluation of adverse effects during bepridil administration for atrial fibrillation and flutter. | 2006-06 |
|
| Characterization of recombinant human cardiac KCNQ1/KCNE1 channels (I (Ks)) stably expressed in HEK 293 cells. | 2006-04 |
|
| Histamine excites neonatal rat sympathetic preganglionic neurons in vitro via activation of H1 receptors. | 2006-04 |
|
| Characterization of the functional and growth properties of long-term cell cultures established from a human somatostatinoma. | 2006-03 |
|
| A Kir2.3-like K+ conductance in mouse cortical collecting duct principal cells. | 2006 |
|
| Effect of p47phox gene deletion on ROS production and oxygen sensing in mouse carotid body chemoreceptor cells. | 2005-12 |
|
| Fenamates and diltiazem modulate lipid-sensitive mechano-gated 2P domain K(+) channels. | 2005-12 |
|
| Monovalent cation leaks in human red cells caused by single amino-acid substitutions in the transport domain of the band 3 chloride-bicarbonate exchanger, AE1. | 2005-11 |
|
| Functional expression of Kir2.x in human aortic endothelial cells: the dominant role of Kir2.2. | 2005-11 |
|
| TASK-like K+ channels mediate effects of 5-HT and extracellular pH in rat dorsal vagal neurones in vitro. | 2005-10-01 |
|
| Erectile dysfunction in mice lacking the large-conductance calcium-activated potassium (BK) channel. | 2005-09-01 |
|
| Kir6.2-deficient mice are susceptible to stimulated ANP secretion: K(ATP) channel acts as a negative feedback mechanism? | 2005-07-01 |
|
| Inhibition of GSK3beta is a common event in neuroprotection by different survival factors. | 2005-06-13 |
|
| Interaction of acetylcholine with Kir6.1 channels heterologously expressed in human embryonic kidney cells. | 2005-05-16 |
|
| Effect of beta-adrenoceptor blockers on human ether-a-go-go-related gene (HERG) potassium channels. | 2005-02 |
|
| Additional repression of activity-dependent c-fos and BDNF mRNA expression by lipophilic compounds accompanying a decrease in Ca2+ influx into neurons. | 2005-01 |
|
| A TASK3 channel (KCNK9) mutation in a genetic model of absence epilepsy. | 2005 |
|
| A thallium-sensitive, fluorescence-based assay for detecting and characterizing potassium channel modulators in mammalian cells. | 2004-12 |
|
| Activation of cardiac human ether-a-go-go related gene potassium currents is regulated by alpha(1A)-adrenoceptors. | 2004-12 |
|
| The effect of cations on the amidase activity of human tissue kallikrein: 1-linear competitive inhibition by sodium, potassium, calcium and magnesium. 2-linear mixed inhibition by aluminium. | 2004-08 |
|
| The renal-specific transporter mediates facilitative transport of organic anions at the brush border membrane of mouse renal tubules. | 2004-08 |
|
| Is postural tremor size controlled by interstitial potassium concentration in muscle? | 2004-07 |
|
| 4-Chloro-benzo[F]isoquinoline (CBIQ) activates CFTR chloride channels and KCNN4 potassium channels in Calu-3 human airway epithelial cells. | 2004-06 |
|
| ET-1 inhibits B-16 murine melanoma cell migration by decreasing K(+) currents. | 2004-06 |
|
| Melatonin receptor agonist 2-iodomelatonin prevents apoptosis of cerebellar granule neurons via K(+) current inhibition. | 2004-03 |
|
| Differential effects of CB1 and opioid agonists on two populations of adult rat dorsal root ganglion neurons. | 2004-02-18 |
|
| Predictors of in-hospital ventricular fibrillation or torsades de pointes in patients with acute symptomatic bradycardia. | 2004-01 |
|
| [Production of aldosterone by rat mesangial cell and the accumulation of extracellular matrix induced by aldosterone]. | 2003-11-10 |
|
| Effects of truncated angiotensins in humans after double blockade of the renin system. | 2003-11 |
|
| Involvement of transient receptor potential-like channels in responses to mGluR-I activation in midbrain dopamine neurons. | 2003-10 |
|
| Allosteric modulation of a neuronal K+ channel by 1-alkanols is linked to a key residue in the activation gate. | 2003-10 |
|
| Molecular features of an alcohol binding site in a neuronal potassium channel. | 2003-09-30 |
|
| Classification and rescue of ROMK mutations underlying hyperprostaglandin E syndrome/antenatal Bartter syndrome. | 2003-09 |
|
| A novel two-pore domain K+ channel, TRESK, is localized in the spinal cord. | 2003-07-25 |
|
| Inhibition of G protein-activated inwardly rectifying K+ channels by fluoxetine (Prozac). | 2003-03 |
|
| Five novel single nucleotide polymorphisms in the CYP2C8 gene, one of which induces a frame-shift. | 2002 |
|
| Familial hypomagnesemia--hypercalciuria and pseudotumor cerebri. | 2001 |
|
| Potassium supplementation in lithium patients: a timely intervention or premature speculation? | 1992-10 |
|
| The role of cell swelling in the stimulation of glycogen synthesis by insulin. | 1992-03-15 |
|
| Life-threatening hyperkalaemia in an elderly patient receiving captopril, furosemide (frusemide) and potassium supplements. | 1992-03-01 |
|
| Studies on digitalis-induced arrhythmias in glucose- and insulin-induced hypokalemia. | 1977-06 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:56:53 GMT 2025
by
admin
on
Mon Mar 31 19:56:53 GMT 2025
|
| Record UNII |
RWP5GA015D
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 176.170
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-VATC |
QC03AB03
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-VATC |
QC03AB09
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
42569-4
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
2825-8
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-ATC |
C03CB02
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-ATC |
C03AB05
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-VATC |
QA12BA03
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-VATC |
QA12BA04
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-ATC |
C03EA14
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
75940-7
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
32336-0
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
77142-8
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
21476-7
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
25506-7
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-VATC |
QC03AB05
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
57380-8
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
56143-1
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
49789-1
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
18372-3
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-ATC |
R05CA02
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
2821-7
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
5927-9
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-VATC |
QC03AB08
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
6940-1
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
79710-0
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-ATC |
C03CB01
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
50902-6
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
2824-1
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
22760-3
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
2958-7
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
2959-5
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
14172-1
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
28003-2
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-ATC |
C03EA04
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-ATC |
C03BB07
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-ATC |
C03AB04
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
CFR |
21 CFR 862.1600
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
6792-6
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
39785-1
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-ATC |
C03AB07
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-VATC |
QC03AB01
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-ATC |
C03AB08
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
58996-0
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
41656-0
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
82722-0
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-VATC |
QC03AB06
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
11148-4
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
13798-4
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
2820-9
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
39790-1
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
2822-5
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
12814-0
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-VATC |
QC03AB02
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
59162-8
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
30549-0
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
87455-2
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
49788-3
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
NCI_THESAURUS |
C1940
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
DSLD |
106 (Number of products:9399)
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-ATC |
C03AB01
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
27441-5
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-VATC |
QC03BB04
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
17795-6
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
57355-0
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
87454-5
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
35677-4
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
32550-6
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-VATC |
QC03BB07
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
43222-9
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
44406-7
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
6298-4
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
56971-5
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
51720-1
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-ATC |
C03BB05
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-ATC |
C03AB09
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-ATC |
V03AB21
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
2823-3
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-VATC |
QC03CB02
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
53123-6
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-ATC |
C03AB03
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-VATC |
QC03AB04
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
57379-0
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
2819-1
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-VATC |
QC03BB05
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
2826-6
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
60218-5
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-VATC |
QC03BB03
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-ATC |
C03AB02
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
9482-1
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
39789-3
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-ATC |
C03AB06
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-ATC |
A12BA01
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-ATC |
C03BB03
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
15202-5
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-ATC |
C03BB04
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-VATC |
QC03BB02
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-VATC |
QC03CB01
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
2829-0
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-ATC |
S01XA04
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-ATC |
C03BB02
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
32713-0
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
2828-2
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
WHO-VATC |
QC03AB07
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
||
|
LOINC |
33949-9
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
Potassium
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
PRIMARY | |||
|
5462222
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
PRIMARY | |||
|
7440-09-7
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
PRIMARY | |||
|
SUB14961MIG
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
PRIMARY | |||
|
RWP5GA015D
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
PRIMARY | |||
|
DB01345
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
PRIMARY | |||
|
26216
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
PRIMARY | |||
|
m8995
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
PRIMARY | Merck Index | ||
|
100000091749
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
PRIMARY | |||
|
D011188
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
PRIMARY | |||
|
231-119-8
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
PRIMARY | |||
|
RWP5GA015D
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
PRIMARY | |||
|
DTXSID9049748
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
PRIMARY | |||
|
8588
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
PRIMARY | RxNorm | ||
|
C765
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
PRIMARY | |||
|
698
Created by
admin on Mon Mar 31 19:56:53 GMT 2025 , Edited by admin on Mon Mar 31 19:56:53 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |